ARC Stock Overview
Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ARCpoint Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.065 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.045 |
| Beta | -1.03 |
| 11 Month Change | -27.78% |
| 3 Month Change | -27.78% |
| 1 Year Change | -35.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARC | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 18.2% | -0.5% | 0.4% |
| 1Y | -35.0% | 41.9% | 21.4% |
Return vs Industry: ARC underperformed the Canadian Healthcare industry which returned 41.9% over the past year.
Return vs Market: ARC underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| ARC volatility | |
|---|---|
| ARC Average Weekly Movement | 29.9% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ARC's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: ARC's weekly volatility (30%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | John Constantine | www.arcpointlabs.com |
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. The company operates in two segments, ARCpoint Franchise and AFG Services. It offers clinical healthcare; viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing and screening; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy, respiratory, and blood type testing services, as well as vaccine, vitamin, and supplements injections.
ARCpoint Inc. Fundamentals Summary
| ARC fundamental statistics | |
|---|---|
| Market cap | CA$7.66m |
| Earnings (TTM) | -CA$10.03m |
| Revenue (TTM) | CA$9.37m |
0.8x
P/S Ratio-0.8x
P/E RatioIs ARC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARC income statement (TTM) | |
|---|---|
| Revenue | US$6.70m |
| Cost of Revenue | US$4.53m |
| Gross Profit | US$2.17m |
| Other Expenses | US$9.35m |
| Earnings | -US$7.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 32.39% |
| Net Profit Margin | -107.02% |
| Debt/Equity Ratio | -60.4% |
How did ARC perform over the long term?
See historical performance and comparison